Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-01-03 20:58 Tx date 2022-12-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Holder: Emergence Innovations Inc (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$12,499
+73,529 vol $0.17 each |
262,499 | |
Filed 2023-01-03 20:56 Tx date 2022-12-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,606
+132,786 vol $0.11 each |
1,040,455 | |
Filed 2023-01-03 20:56 Tx date 2022-12-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$22,573
+132,787 vol $0.17 each |
907,669 | |
Filed 2023-01-03 20:53 Tx date 2022-12-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Holder: Luca Pani, MD Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,108
+82,992 vol $0.17 each |
316,518 | |
Filed 2022-11-30 18:34 Tx date 2022-11-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Holder: Emergence Innovations Inc (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$12,499
+69,444 vol $0.18 each |
188,970 | |
Filed 2022-11-30 18:33 Tx date 2022-11-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$45,260
+251,449 vol $0.18 each |
774,882 | |
Filed 2022-11-30 18:31 Tx date 2022-11-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Holder: Luca Pani, MD Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,144
+78,578 vol $0.18 each |
233,526 | |
Filed 2022-11-11 17:17 Tx date 2022-10-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Parks, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+100,000 vol |
180,000 | |
Filed 2022-11-04 14:59 Tx date 2022-04-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
$22,500,000,000
+150,000 vol $150,000 each |
||
Filed 2022-11-04 14:58 Tx date 2022-04-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+150,000 vol $0.70 each |
||
Filed 2022-04-28 10:26 Tx date 2022-04-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
$22,500,000,000
+150,000 vol $150,000 each |
||
Filed 2022-04-28 10:25 Tx date 2022-04-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+150,000 vol $0.70 each |
||
Filed 2022-11-03 19:32 Tx date 2022-10-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$160,000
+500,000 vol $0.32 each |
500,000 | |
Filed 2022-11-03 19:15 Tx date 2022-10-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
400,000 | |
Filed 2022-11-03 17:04 Tx date 2022-10-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Joseph, Geraci
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+100,000 vol $0.35 each |
100,000 | |
Filed 2022-11-03 17:04 Tx date 2021-10-27 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Joseph, Geraci
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-11-03 16:59 Tx date 2022-10-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$43,750
+125,000 vol $0.35 each |
325,000 | |
Filed 2022-11-03 13:46 Tx date 2022-04-06 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Warrants Expires Oct. 31, 2025
00 - Opening Balance-Initial SEDI Report
|
1,260,000 | ||
Filed 2022-11-03 13:45 Tx date 2022-11-03 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
500,000 | |
Filed 2022-11-01 21:18 Tx date 2022-10-12 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Warrants
30 - Acquisition or disposition under a purchase/ownership plan
|
$120,000
+300,000 vol $0.40 each |
300,000 | |
Filed 2022-11-01 21:17 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-11-01 21:16 Tx date 2022-10-12 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$75,000
+300,000 vol $0.25 each |
300,000 | |
Filed 2022-11-01 21:16 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Holder: Jaitly 2020 Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-11-01 20:52 Tx date 2022-10-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Holder: Emergence Innovations Inc (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$12,499
+36,764 vol $0.34 each |
119,526 | |
Filed 2022-11-01 20:50 Tx date 2022-10-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$45,384
+133,483 vol $0.34 each |
523,433 | |
Filed 2022-11-01 20:49 Tx date 2022-10-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Holder: Luca Pani, MD Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,182
+41,713 vol $0.34 each |
154,948 | |
Filed 2022-10-17 16:15 Tx date 2022-10-14 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Holder: A2 Capital Management (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+500,000 vol |
825,000 | |
Filed 2022-10-17 16:14 Tx date 2022-10-14 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Holder: A2 Capital Management (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$125,000
+500,000 vol $0.25 each |
3,503,500 | |
Filed 2022-10-14 20:40 Tx date 2022-10-14 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black Inc. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+40,000 vol |
40,000 | |
Filed 2022-10-14 20:39 Tx date 2022-07-18 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-14 20:39 Tx date 2022-10-14 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black Inc. (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,000
+40,000 vol $0.25 each |
40,000 | |
Filed 2022-10-14 20:38 Tx date 2022-07-18 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Holder: Red to Black Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-03 19:35 Tx date 2022-08-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
Filed 2022-10-03 19:35 Tx date 2022-08-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Holder: Emergence Innovations Inc (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,762 | ||
Filed 2022-10-03 19:35 Tx date 2022-08-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-03 19:34 Tx date 2022-08-15 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-03 19:30 Tx date 2022-09-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Holder: Emergence Innovations Inc (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$12,500
+50,000 vol $0.25 each |
82,762 | |
Filed 2022-10-03 19:29 Tx date 2022-08-15 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Holder: Emergence Innovations Inc (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-03 19:12 Tx date 2022-08-31 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$43,587
+136,211 vol $0.32 each |
207,187 | |
Filed 2022-10-03 19:10 Tx date 2022-07-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-03 19:10 Tx date 2022-09-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$45,690
+182,763 vol $0.25 each |
389,950 | |
Filed 2022-10-03 18:59 Tx date 2022-09-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
45 - Compensation for property
|
$45,690
+182,763 vol $0.25 each |
253,739 | |
Filed 2022-10-03 18:59 Tx date 2022-09-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
45 - Compensation for property
|
$45,690
+182,763 vol $0.25 each |
||
Filed 2022-10-03 18:52 Tx date 2022-09-30 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Holder: Luca Pani, MD Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,278
+57,114 vol $0.25 each |
113,235 | |
Filed 2022-08-25 10:19 Tx date 2022-08-15 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-09-07 14:50 Tx date 2022-09-02 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Holder: Luca Pani, MD Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$13,621
+42,566 vol $0.32 each |
56,121 | |
Filed 2022-08-25 10:19 Tx date 2022-08-15 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Douglas J., Cook
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-08-03 16:55 Tx date 2022-07-20 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$143,500
+350,000 vol $0.41 each |
400,000 | |
Filed 2022-08-03 16:53 Tx date 2022-07-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2022-08-03 16:49 Tx date 2022-07-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Options
50 - Grant of options
|
$200,000
+500,000 vol $0.40 each |
500,000 | |
Filed 2022-08-03 16:47 Tx date 2022-07-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-08-03 16:26 Tx date 2022-07-29 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$24,841
+70,976 vol $0.35 each |
70,976 | |
Filed 2022-08-03 16:25 Tx date 2022-07-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Spiegel, Joshua Justin
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: JJS LifeSci Consulting, LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-08-02 13:51 Tx date 2022-07-29 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Holder: Luca Pani, MD Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$4,744
+13,555 vol $0.35 each |
13,555 | |
Filed 2022-08-02 13:47 Tx date 2022-07-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Holder: Luca Pani, MD Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-08-02 13:46 Tx date 2022-07-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Pani, Luca
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-20 19:10 Tx date 2022-07-18 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$104,000
+200,000 vol $0.52 each |
200,000 | |
Filed 2022-07-20 19:09 Tx date 2022-07-18 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-18 20:05 Tx date 2022-07-18 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Kakumanu, Swapan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-06-14 13:55 Tx date 2022-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+62,500 vol |
62,500 | |
Filed 2022-06-14 13:54 Tx date 2022-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+125,000 vol $0.40 each |
125,000 | |
Filed 2022-06-14 13:54 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-06-14 13:53 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-06-10 12:15 Tx date 2022-04-06 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Holder: A2 Capital Management (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
325,000 | ||
Filed 2022-06-08 17:42 Tx date 2022-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Holder: A2 Capital Management (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$260,000
+650,000 vol $0.40 each |
3,003,500 | |
Filed 2022-04-28 10:26 Tx date 2022-04-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
$22,500,000,000
+150,000 vol $150,000 each |
350,000 | |
Filed 2022-04-28 10:25 Tx date 2022-04-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+150,000 vol $0.70 each |
360,000 | |
Filed 2022-04-28 09:51 Tx date 2022-04-25 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Holder: A2 Capital Management (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+3,500 vol $0.40 each |
2,353,500 | |
Filed 2022-04-27 17:06 Tx date 2022-04-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$210,000
+300,000 vol $0.70 each |
500,000 | |
Filed 2022-04-27 17:04 Tx date 2022-04-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$87,500
+125,000 vol $0.70 each |
200,000 | |
Filed 2022-04-20 11:35 Tx date 2022-04-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Parks, Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
Filed 2022-04-20 11:35 Tx date 2021-05-25 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Parks, Andrew
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-04-18 10:33 Tx date 2022-04-13 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
56 - Grant of rights
|
+250,000 vol |
250,000 | |
Filed 2022-04-18 10:32 Tx date 2021-08-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-04-13 12:48 Tx date 2022-04-06 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
210,000 | ||
Filed 2022-04-13 12:14 Tx date 2022-04-06 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-04-13 12:13 Tx date 2022-04-06 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2022-04-13 12:13 Tx date 2022-04-06 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
Filed 2022-04-13 12:13 Tx date 2022-04-06 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
DeMichele, Luigi Gino
4 - Director of Issuer
Holder: A2 Capital Management (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,350,000 | ||
Filed 2022-03-30 15:57 Tx date 2022-03-25 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Sing, Blake
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$135,000
+150,000 vol $0.90 each |
300,000 | |
Filed 2022-03-25 14:16 Tx date 2022-03-21 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-425,000 vol |
75,000 | |
Filed 2021-11-29 17:24 Tx date 2021-11-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Taylor, Kevin Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2021-11-26 13:43 Tx date 2021-11-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Taylor, Kevin Robert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
80,000 | ||
Filed 2021-11-26 13:43 Tx date 2021-11-23 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Taylor, Kevin Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$120,000
+75,000 vol $1.60 each |
75,000 | |
Filed 2021-11-26 13:42 Tx date 2021-11-22 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Taylor, Kevin Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-11-19 17:00 Tx date 2021-11-11 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
500,000 | |
Filed 2021-11-19 16:57 Tx date 2021-11-11 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
500,000 | |
Filed 2021-11-19 16:57 Tx date 2021-11-11 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
||
Filed 2021-11-16 11:32 Tx date 2021-08-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
Filed 2021-09-03 16:15 Tx date 2021-08-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-10-27 16:01 Tx date 2021-10-15 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Geraci, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,057,963
+4,333,954 vol $2.09 each |
4,333,954 | |
Filed 2021-10-27 15:59 Tx date 2021-10-15 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Geraci, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-28 18:43 Tx date 2021-09-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
BATH, Ranjit
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1.40
+1 vol $1.40 each |
50,001 | |
Filed 2021-09-28 18:36 Tx date 2021-06-10 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
BATH, Ranjit
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$45,000
+50,000 vol $0.90 each |
50,000 | |
Filed 2021-06-24 18:10 Tx date 2021-06-10 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
BATH, Ranjit
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$450,000
+500,000 vol $0.90 each |
||
Filed 2021-09-03 16:16 Tx date 2021-08-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-03 16:15 Tx date 2021-08-24 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Achilleos, George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
Filed 2021-06-24 18:10 Tx date 2021-06-10 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
BATH, Ranjit
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$450,000
+500,000 vol $0.90 each |
500,000 | |
Filed 2021-06-24 18:08 Tx date 2020-12-04 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
BATH, Ranjit
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-15 17:51 Tx date 2021-06-09 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
BATH, Ranjit
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+500,000 vol $0.90 each |
500,000 | |
Filed 2021-06-15 17:46 Tx date 2020-12-04 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
BATH, Ranjit
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-14 14:59 Tx date 2021-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Parks, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,000 vol |
80,000 | |
Filed 2021-06-14 14:58 Tx date 2021-05-25 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Parks, Andrew
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-11 15:17 Tx date 2021-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Stewart, Kirstine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$54,000
+60,000 vol $0.90 each |
60,000 | |
Filed 2021-06-11 15:16 Tx date 2021-03-11 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Stewart, Kirstine
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-11 15:12 Tx date 2021-06-08 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$54,000
+60,000 vol $0.90 each |
60,000 | |
Filed 2021-06-11 15:10 Tx date 2020-06-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Jaitly, Sheetal
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-10 16:47 Tx date 2021-06-09 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Sing, Blake
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$135,000
+150,000 vol $0.90 each |
150,000 | |
Filed 2021-06-10 16:44 Tx date 2021-02-01 |
$MEND
Nurosene Health Inc. (formerly Nurosene Inc.) |
Sing, Blake
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|